Innovation in the medical device sector: An open business model approach for high-tech small firms

Technology Analysis and Strategic Management

Volumn 23, Issue 8, 2011, Pages 807-824

  Davey, Shirley M ^a   Brennan, Michael ^a,b   Meenana, Brian J ^a   McAdam, Rodney ^b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Business model; Health care; Hi tech industries; Innovation strategy; Innovation studies; Technology and innovation studies

Indexed keywords

BUSINESS DEVELOPMENT; BUSINESS SERVICE; HEALTH CARE; HIGH TECHNOLOGY INDUSTRY; INNOVATION; MEDICINE; QUALITATIVE ANALYSIS; STAKEHOLDER;

EID: 80052138772     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537325.2011.604152     Document Type: Article

References (46)

1. ABHI. The Association of British Healthcare Industries. http://www.abhi.org.uk/(accessed 2 November 2009).
2. AdvaMed. 2004. Annual report. Washington, DC: Advanced Medical Technology Association.
3. Albury, D. 2004. Innovation in the public sector, strategy unit. London: Cabinet Office.
4. Bandara, W. 2006. Using NVivo as a research management tool: A case narrative. In Quality and impact of qualitative research, ed. A. Ruth. Third Annual QuaIIT Conference. Brisbane: Institute for Integrated and Intelligent Systems, Griffith University, South Brisbane, Queensland, Australia.
5. Bernstein, B., and P. Singh. 2006. An integrated innovation process model based on practices of Australian biotechnology firms. Technovation 26, no. 5: 561-72.
6. Brown, A., and E. Soderstrom. 2002. Start-up and equity primer. Yale, Association of University Technology Managers Publication. New Haven, CT:Yale University.
7. Chatterji, A.K. 2009. Spawned with a silver spoon? Entrepreneurial performance and innovation in the medical device industry. Strategic Management Journal 30, no. 2: 185-206.
8. Chesbrough, H. 2006. Open business models. Boston, MA: Harvard Business School Press.
9. Chesbrough, H. 2009. How open innovation can help you cope in lean times. Harvard Business Review 87, no. 12: 68-76.
10. Christensen, C.M., and M. Overdorf. 2000. Meeting the challenge of disruptive change. Harvard Business Review 78, no. 2: 67-77.
11. Consoli, D., and A. Mina. 2009. An evolutionary perspective on health innovation systems. Journal of Evolutionary Economics 19, no. 2: 297-319.
12. Cosh, E., A. Girling, R. Lilford, H. McAteer, and T. Young. 2007. Investing in new medical technologies: A decision framework. Journal of Commercial Biotechnology 13, no. 4: 263-71.
13. Dixon, D., A. Brown, B.J. Meenan, and J. Eatock. 2006. Experiences of new product development in the medical device industry. Medical Device Technology 17, no. 3: 20-2.
14. European Commission. 2009. Sixth framework programme. http://www.converging-technologies.org/(accessed 30 September 2009).
15. Faulkner, A. 2009. Regulatory policy as innovation: Constructing rules of engagement for a technological zone of tissue engineering in the European Union. Research Policy 38, no. 4: 637-46.
16. Fuller, S. 2009. Knowledge politics and new converging technologies: A social epistemological perspective. Innovation: The European Journal of Social Science Research 22, no. 1: 7-34.
17. Frost & Sullivan. 2008. US medical devices market outlook. N1A5-54. Palo Alto, CA: Frost & Sullivan.
18. Gibbs, G.R. 2002. Qualitative data analysis: Explorations with NVivo. Buckingham, UK: Open University Press.
19. Griffin, A. 2007. UK nears European average in proportion of GDP spent on health care. British Medical Journal March 3 334: 443.
20. Hansen, M.T. 2009. When internal collaboration is bad for your company. Harvard Business Review 84, no. 3: 83-91.
21. Hansen, M.T., and J. Birkinshaw. 2007. The innovation value chain. Harvard Business Review 85, no. 6: 121-33.
22. Humphreys, P., R. McAdam, and J. Leckey. 2005. Longitudinal evaluation of innovation implementation in SMEs. European Journal of Innovation Management 8, no. 3: 283-304.
23. Kaiser, H.J. 2009. Healthcare costs: A primer, key information on healthcare costs and their impact. http://www.kff.org (accessed March 2009).
24. Kaplan, A.V., D.S. Baim, J.J. Smith, D.A. Feigal, M. Simons, D. Jefferys, T.J. Fogarty, R.E. Kuntz, and M.B. Leon. 2004. Medical device development: From prototype to regulatory approval. Circulation 109: 3068-72.
25. Leydesdorff, L., and M. Meyer. 2003. The triple helix of university-industry-government relations. Scientometrics 58, no. 2: 191-203.
26. Lilford, R., H. McAteer, E. Cosh, G. Freeman, A. Pandit, and P. Wood. 2007. Cost-effectiveness analysis at the development phase of a potential health technology: Examples based on tissue engineering of bladder and urethra. Tissue Engineering and Regenerative Medicine 1, no. 5: 343-9.
27. Lysaght, M.J., and A.L. Hazlehurst. 2004. Tissue engineering: The end of the beginning. Tissue Engineering 10, no. 1-2: 309-20.
28. Maisel, W.H. 2004. Medical device regulation: An introduction for the practicing physician. Annals Internal Medicine 140, no. 4: 296-302.
29. Malaviya, P., and S. Wadhwa. 2005. Innovation management in organizational context:An empirical study. Global Journal of Flexible Systems Management 6, no. 2: 1-14.
30. Martin, J.L., E. Murphy, J.A. Crowe, and B.J. Norris. 2006. Capturing user requirements in medical device development: The role of ergonomics. Physiological Measurement 27, no. 8: R49-R62.
31. Medical Device Outlook. 2009. United Kingdom medical device market intelligence report, Espicom Business Intelligence, Quarter I 2009. Chichester, UK: Espicom.
32. McAdam, R., R. Reid, and D. Gibson. 2004. Innovation and organisational size in Irish SMEs: An empirical study. International Journal of Innovation Management 8, no. 2: 147-65.
33. McLellan, I. 2009. Implementing innovation. Presentation by GE Healthcare, MATCH Workshop, University of Ulster, N. Ireland, 22 April 2009.
34. Osterwalder, A., and Y. Pigneur. 2009. Business model generation. A handbook for visionaries, game changers, and challengers. Chichester: John Wiley and Sons.
35. Palmer, J. 2000. Spare body parts. Barron's 80, no. 2: H20.
36. Porter, M.E., and M.R. Kramer. 2006. Strategy and society: The link between competitive advantage and corporate social responsibility. Harvard Business Review 84, no. 12: 78-92.
37. Roco, M.C., and W.S. Bainbridge. 2003. Converging technologies for improving human performance. Dordrecht: Netherlands: Kluwer Academic Publications.
38. Shah, S.G.H., and I. Robinson. 2006. User involvement in healthcare technology development and assessment. International Journal of Health Care Quality Assurance 19, no. 6: 500-15.
39. Siska, A. 2009. Health spending projections through 2018: Recession effects add uncertainty to the outlook. Health Affairs 28, no. 2: 346-57.
40. Stake, R.E. 2005. Multiple case study analysis. 1st edition. New York: The Guildford Press.
41. Statistics Cananda. 2006. Labour force survey. Ottawa: Statistics Canada.
42. Tidd, J., J. Bessant, and K. Pavitt. 2009. Managing innovation: Integrating technological market and organisational change. 3rd edition. Chichester: John Wiley and Sons.
43. Tijsse, R.J.W. 2009. Internationalisation of pharmaceutical Rand D: How globalised are Europe's largest multinational companies? Technology Analysis and Strategic Management 21, no. 7: 859-79.
44. Vallejo-Torres, L., L.M.G. Steuten, M.J. Buxton, A.J. Girling, R.J. Lilford, and T. Young. 2008. Integrating health economics modeling in the product development cycle of medical devices:A Bayesian approach. International Journal of Technology Assessment in Health Care 24, no. 4: 459-64.
45. Wright, M., S. Birley, and S. Mosey. 2004. Entrepreneurship and university technology transfer. Journal of Technology Transfer 29, no. 3-4: 235-46.
46. Yin, R.K. 2003. Applications of case study research: Design and methods. 2nd edition Vol. 3. Applied Social Research Methods Series. London:Sage.